Treating IgG4-related disease with rituximab 39673q

Rheumatology, Oxford Journals

12/09/2016

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in...

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.

Dr Steven Zhao on comorbidities and disease activity in axSpA 6 días 07:54 Dr Marwan Bukhari talks to Dr Helena Marzo-Ortega on the use of MRI in the diagnosis of axSpA +1 año 06:07 Trainee Publishing Programme 2021: Dr Sreejitha Sreevilasan +1 año 09:46 Dr. Iona Thorne on reproductive health in women with rheumatic disease +1 año 14:26 Dr John Hanly on lupus nephritis +1 año 04:07 Ver más en APP Comentarios del episodio 4mi1k